Pacific Biosciences's total assets for Q1 2025 were $860.79M, a decrease of -31.71% from the previous quarter. PACB total liabilities were $769.15M for the fiscal quarter, a 2.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.